Dr. Lasky-Su is an Associate Professor in Medicine and associate statistician at Harvard Medical School and Brigham and Women’s Hospital. Over the last 19 years, she has focused on the analysis of genetics, genomics, and metabolomics data of various complex diseases with a primary focus on asthma over the last 15 years. The accumulation of these efforts has resulted in a productive track record of over 130 original research articles. Her ongoing metabolomics-based R01 grants, “The Integrative Metabolomics of Asthma Severity” (PI, R01HL123915), “Mechanistic insights into asthma pathogenesis through the integration of asthma genes, risk exposures, and metabolomics” (PI, R01HL141826) have enabled her to develop a metabolomics epidemiology research program at the Channing Division of Network Medicine that focuses on using metabolomics to study the etiology of complex diseases, including a diverse range of diseases including asthma, allergies, autism, bacteremia, and macular degeneration among others. She has also focused on using metabolomics data in conjunction with other omics data to study disease etiology and has published several papers using a variety approaches to integrative omics. Dr. Lasky-Su serves in several metabolomics leadership capacities including being the acting chairman of the Consortium of METabolomic Studies (COMETS), a board member of the International Metabolomics Society, and an advisory member to the Metabolomics Workbench.